Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Nasopharyngeal Carcinoma 71Nasopharyngeal Neoplasms 25Head and Neck Neoplasms 25Squamous Cell Carcinoma of Head and Neck 18Neoplasm Metastasis 14Carcinoma, Non-Small-Cell Lung 11Recurrence 9Salivary Gland Neoplasms 7Ovarian Neoplasms 7Stomach Neoplasms 6Pancreatic Neoplasms 6Small Cell Lung Carcinoma 5Prostatic Neoplasms 5Neoplasms 5Melanoma 5Colorectal Neoplasms 5Breast Neoplasms 5Triple Negative Breast Neoplasms 4Sarcoma 4Lung Neoplasms 4Esophageal Neoplasms 4Urinary Bladder Neoplasms 3Thyroid Neoplasms 3Laryngeal Diseases 3Epstein-Barr Virus Infections 3Colonic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Osteosarcoma 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2

Interventions

Cisplatin 13Cetuximab 10Radiotherapy 7pembrolizumab 4Pemetrexed 4Fluorouracil 4Docetaxel 4Gemcitabine 3durvalumab 2Surveys and Questionnaires 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Narrow Band Imaging 2N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Gefitinib 2Drug Therapy 2Carboplatin 2tremelimumab 1niraparib 1monalizumab 1linrodostat 1dostarlimab 1capmatinib 1X-Rays 1Vitamin B 12 1Tirapazamine 1Tablets 1Surgical Flaps 1Sugars 1Radiotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Laryngeal Diseases × Gemcitabine × Head & Neck × Clear all
NCT01172470 2023-11-29

Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients

University of Chicago

Phase 2 Completed
34 enrolled
Head & Neck

Lymphoid Interstitial Pneumonia, Head and Neck Neoplasms, Laryngeal Diseases

NCT00589667 2014-04-02

A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
26 enrolled 8 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Head and Neck Neoplasms, Laryngeal Diseases

NCT00100789 2012-10-01

S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

SWOG Cancer Research Network

Phase 2 Completed
67 enrolled 10 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡